Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic SclerosisJacob M. van Laar, A Tyndall, Dominique Farge et al.|JAMA|2014Cited by 739
High-Dose Cytarabine in Induction Treatment Improves the Outcome of Adult Patients Younger Than Age 46 Years With Acute Myeloid Leukemia: Results of the EORTC-GIMEMA AML-12 TrialR. Willemze, Théo de Witte, Francesco Fabbiano et al.|Journal of Clinical Oncology|2013Cited by 168
Treatment of patients with MYC rearrangement positive large B-cell lymphoma with R-CHOP plus lenalidomide: results of a multicenter HOVON phase II trialMartine E.D. Chamuleau, Marie José Kersten, Coreline N. Burggraaff et al.|Haematologica|2019Cited by 53
Feasibility and efficacy of addition of individualized-dose lenalidomide to chlorambucil and rituximab as first-line treatment in elderly and FCR-unfit patients with advanced chronic lymphocytic leukemiaArnon P. Kater, Mark‐David Levin, Marinus H. J. van Oers et al.|Haematologica|2018Cited by 13
Proteomic markers with prognostic impact on outcome of chronic lymphocytic leukemia patients under chemo-immunotherapy: results from the HOVON 109 studyFatemeh Saberi Hosnijeh, Mark‐David Levin, Arnon P. Kater et al.|Experimental Hematology|2020Cited by 8